Bill Text: NY S05529 | 2019-2020 | General Assembly | Introduced


Bill Title: Requires the commissioner of health to develop guidelines for the prescription of opioid antagonists.

Spectrum: Slight Partisan Bill (Republican 2-1)

Status: (Introduced) 2019-05-06 - REFERRED TO HEALTH [S05529 Detail]

Download: New_York-2019-S05529-Introduced.html


                STATE OF NEW YORK
        ________________________________________________________________________
                                          5529
                               2019-2020 Regular Sessions
                    IN SENATE
                                       May 6, 2019
                                       ___________
        Introduced by Sens. MARTINEZ, AMEDORE -- read twice and ordered printed,
          and when printed to be committed to the Committee on Health
        AN  ACT  to  amend  the  public health law, in relation to requiring the
          commissioner of health to develop guidelines for  the  prescribing  of
          opioid antagonists
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
     1    Section 1. The public health law is amended by adding  a  new  section
     2  3346 to read as follows:
     3    §  3346. Guidelines for the prescribing of opioid antagonists. 1.  The
     4  commissioner shall adopt guidelines for the prescribing of opioid antag-
     5  onists that are applicable to all licensed health care providers in  the
     6  state  who  are authorized to prescribe an opioid analgesic. Such guide-
     7  lines must address:
     8    (a) prescribing an opioid antagonist to a patient to  whom  an  opioid
     9  medication is also prescribed; and
    10    (b)  identifying  patients  at risk of an opioid-related drug overdose
    11  and prescribing an opioid antagonist to that patient or to a person in a
    12  position to administer the opioid antagonist to that patient.
    13    2. In adopting guidelines under this section, the  commissioner  shall
    14  consult  with the state board of pharmacy as well as materials published
    15  by, but not limited to, the substance abuse and mental  health  services
    16  administration  of  the  United  States  department  of health and human
    17  services and other appropriate  materials,  including  medical  journals
    18  subject  to peer review and publications by medical professional associ-
    19  ations.
    20    3. The commissioner is authorized to promulgate rules and  regulations
    21  necessary for the implementation of this section.
    22    § 2. This act shall take effect on the one hundred eightieth day after
    23  it shall have become a law.  Effective immediately, the addition, amend-
    24  ment and/or repeal of any rule or regulation necessary for the implemen-
    25  tation  of  this act on its effective date are authorized to be made and
    26  completed on or before such effective date.
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD01603-02-9
feedback